In this webinar, Dr. Jamuar discusses the optimal technique for the detection of somatic mosaicism. He evaluates the limitations of Sanger sequencing and highlights the advantages of targeted next-generation sequencing (NGS), sharing findings from his paper, Somatic Mutations in Cerebral Cortical Malformations that was published in the New England Journal of Medicine.

Webinar at a glance

• Learn about somatic mutations and threshold of detection. 
• Understand the prevalence of somatic mutations in neurodevelopmental disease.
• Evaluate an optimal technique for somatic mosaicism detection
• Limitations of Sanger sequencing
• Advantages of targeted NGS Presenter: Dr. Saumya Jamuar Consultant, Genetics Service KK Women's and Children's Hospital, Singapore

A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015.

Subscribe to the Illumina video channel 

View customer spotlight videos

View Illumina webinars

View Illumina product videos

View Illumina support videos